Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Albert Labs files provisional patent in the US for its Psilocybe mycelia cultivation process

Albert Labs files provisional patent in the US for its Psilocybe mycelia cultivation process

Albert Labs Head of Scientific Advisory Board Parminder Singh joined Proactive to discuss a provisional patent application the group has filed in the US, covering its proprietary cultivation process for the production of Psilocybe mycelia and other types of fungi. The research and drug development company has developed a process that it says can significantly boost the production volumes of psilocybin medicine.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK